Join Crystal Pharmatech at CPHI Milan, Booth 10H51, from October 06–08, 2026, in Milan, Italy.
As a technology-driven CRO/CDMO, we invite you to discover how our "First-Time-Right" approach delivers strategic, phase-appropriate solutions that de-risk drug development and accelerate your development of new medicines.
What you will take away from Crystal Pharmatech:
Our experts will lead in-depth discussions on how our three specialized platforms can de-risk your 2026 development goals:
Small Molecule: Solid-State Research, Preformulation, and CMC Formulation Development through to GMP Manufacturing (First-Time-Right approach).
Biologics (Crystal Bio Solutions): Biologics Characterization & CMC Analytical services, Bioanalysis & Biomarker, and Quantitative Clinical Pharmacology.
Nucleic Acids (Crystal NAX): End-to-end solutions for nucleic acid therapeutics.
Co-founder & CEO
Crystal Pharmatech
CEO of Canada CDMO BU
Candoo Pharmatech
Senior Director, Business Development
Crystal Pharmatech
Business Development Manager
Crystal NAX
When: October 06-08, 2026
Where: Fiera Milano, Italy
Find Us: Booth 10H51
Subscribe to be the first to get the updates!
